XML 34 R8.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income
Balance at period start (in shares) at Dec. 31, 2019   53,254      
Balance at period start at Dec. 31, 2019 $ 648,242 $ 533 $ 715,069 $ (67,942) $ 582
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock for employee stock purchase plan (in shares)   145      
Issuance of common stock for employee stock purchase plan 1,553 $ 2 1,551    
Exercise of stock option / common stock warrants (in shares)   351      
Exercise of stock option / common stock warrants 3,936 $ 3 3,933    
Share-based compensation (in shares)   322      
Stock-based compensation 7,109 $ 3 7,106    
Purchase of common stock for retirement (in shares)   (69)      
Purchase of common stock for retirement (1,156) $ (1) (1,155)    
Other comprehensive income (4,324)       (4,324)
Net income (loss) (409,086)     (409,086)  
Balance at period end (in shares) at Dec. 31, 2020   54,003      
Balance at period end at Dec. 31, 2020 246,274 $ 540 726,504 (477,028) (3,742)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock for employee stock purchase plan (in shares)   85      
Issuance of common stock for employee stock purchase plan 1,421 $ 1 1,420    
Common stock offering, net of issuance costs (in shares)   5,750      
Common stock offering, net of issuance costs 87,193 $ 58 87,135    
Exercise of stock option / common stock warrants (in shares)   4      
Exercise of stock option / common stock warrants 58   58    
Share-based compensation (in shares)   443      
Stock-based compensation 7,952 $ 4 7,948    
Purchase of common stock for retirement (in shares)   (123)      
Purchase of common stock for retirement (2,145) $ (1) (1,352) (792)  
Other comprehensive income 6,244       6,244
Net income (loss) (81,297)     (81,297)  
Balance at period end (in shares) at Dec. 31, 2021   60,162      
Balance at period end at Dec. 31, 2021 265,700 $ 602 821,713 (559,117) 2,502
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock for employee stock purchase plan (in shares)   67      
Issuance of common stock for employee stock purchase plan 1,244   1,244    
Exercise of stock option / common stock warrants (in shares)   349      
Exercise of stock option / common stock warrants 6,444 $ 4 6,440    
Share-based compensation (in shares)   417      
Stock-based compensation 9,166 $ 3 9,163    
Purchase of common stock for retirement (in shares)   (524)      
Purchase of common stock for retirement (7,833) $ (5) (2,069) (5,759)  
Other comprehensive income 5,627       5,627
Net income (loss) 364,189     364,189  
Balance at period end (in shares) at Dec. 31, 2022   60,471      
Balance at period end at Dec. 31, 2022 $ 644,537 $ 604 $ 836,491 $ (200,687) $ 8,129